Full-Time

Referral Specialist

LUX Infusion

LUX Infusion

1-10 employees

Outpatient infusion centers for IV therapies

Compensation Overview

$25 - $30/hr

Las Vegas, NV, USA

In Person

On-site in Las Vegas, Nevada; occasional travel up to 5% for business; work hours align with Pacific Time Zone.

Category
Administrative & Executive Assistance (1)
Required Skills
Word/Pages/Docs
Excel/Numbers/Sheets

Get referred to LUX Infusion

See people who can refer or advise you

Requirements
  • High school diploma or GED
  • Minimum of one (1) year of experience managing patient referrals, prescription activities, or reimbursement services in infusion or specialty therapies
  • Minimum of one (1) year of customer service experience in a healthcare setting (patient or provider‑facing)
  • Experience with electronic health records or pharmacy patient management systems
  • Working knowledge of medical or pharmacy terminology
  • Proficiency with Microsoft Office (Word, Excel, PowerPoint)
  • Ability to travel up to 5% for business needs, as required
Responsibilities
  • Serve as the primary point of contact for assigned referral sources, patients, and aligned field‑based sales partners
  • Navigate new referrals from receipt through service determination within the LUX Infusion pharmacy network
  • Build and maintain strong, trusted relationships with prescribers, providers, and healthcare staff through timely, professional communication
  • Collect and coordinate required referral information, including patient demographics, benefits, clinical history, and prescription details
  • Partner closely with Reimbursement Specialists to communicate benefit investigation outcomes, including patient responsibility and financial assistance options
  • Coordinate with Nurse Coordination teams to support patients requiring in‑home nursing services
  • Collaborate with Pharmacy Operations to ensure clinical and fulfillment teams have what they need to onboard and support new patients
  • Maintain accurate documentation of referral activity and communications within systems of record
  • Manage referral volume, turnaround times, and workload priorities to meet service goals
  • Use technology and digital tools effectively to communicate with internal and external stakeholders
  • Bring thoughtfulness, reliability, and accountability to every referral you support
Desired Qualifications
  • Bachelor’s degree
  • Experience supporting prescriber, patient, and field‑facing communications related to infusion or specialty therapy referrals
  • General understanding of prescription benefits, payer requirements, and verification processes
  • Familiarity with infusion therapy workflows and patient needs

LUX Infusion provides ambulatory infusion services in Alaska, delivering IV and injectable therapies outside hospital settings in spa-like centers in Anchorage, Palmer, and Fairbanks. A clinical team of physicians, nurse practitioners, and infusion nurses collaborates with referring providers, while centers handle pre-authorizations and financial assistance, serving patients with private insurance, Medicare, and Medicaid. In 2025, LUX Infusion was acquired by BioMatrix Infusion Pharmacy, integrating its care teams into a national ambulatory infusion network to expand the Pacific Northwest and accelerate growth; the company holds NICA accreditation and the AICE-Ambulatory Infusion Center of Excellence designation. Its goal is to provide high-quality, patient-centered outpatient infusion care that reduces medical costs and offers an alternative to hospital-based treatment.

Company Size

1-10

Company Stage

N/A

Total Funding

N/A

Headquarters

Anchorage, Alaska

Founded

2022

Get referred to LUX Infusion

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • August 6, 2026 Infuse IQ acquisition expands LUX beyond Alaska into Wyoming.
  • May 28, 2026 Dan Teich promotion strengthens managed care, trade relations, and market access.
  • BioMatrix says LUX helps scale toward fifty locations, creating hiring and expansion demand.

What critics are saying

  • BioMatrix owns LUX since October 2025, so headquarters can rationalize staffing anytime.
  • August 2026 Infuse IQ integration adds complexity; failures disrupt six Wyoming clinics and Alaska operations.
  • Payor and manufacturer leverage sit with BioMatrix; reimbursement pressure can squeeze margins by 2027.

What makes LUX Infusion unique

  • October 2025 BioMatrix acquired LUX, proving Alaska-based ambulatory infusion across three centers.
  • LUX earned NICA accreditation and AICE-Ambulatory Infusion Center of Excellence status in 2025.
  • Clinician-led, patient-centered facilities differentiate LUX from hospital-based infusion, emphasizing comfort and cost reduction.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Company News

PR Newswire
Aug 6th, 2026
LUX Infusion Acquires Infuse IQ, Expanding Its National Ambulatory Infusion Footprint

/PRNewswire/ -- LUX Infusion, a clinician-led infusion services company, today announced the acquisition of Infuse IQ, a trusted Wyoming-headquartered...

LUX Infusion
May 28th, 2026
LUX Infusion promotes Dan Teich to Senior Vice President, Market Access.

LUX Infusion promotes Dan Teich to Senior Vice President, Market Access. Unified leadership role aligns trade relations and managed care to strengthen distribution, manufacturer, and payor partnerships. [Plantation, FL] - May 28, 2026 - LUX Infusion, a U.S.-based, clinician-led infusion services company, today announced the promotion of Dan Teich to Senior Vice President, Market Access. In this expanded role, Teich will lead a unified market access function that brings together the company's trade relations and managed care operations under a single, cohesive strategy designed to deepen alignment with LUX Infusion's distribution, manufacturer, and payor partners. "Dan has been an exceptional leader in shaping our trade relationships, and this promotion reflects both his contributions and our confidence in his vision," said Ted Kramm, Chief Executive Officer of LUX Infusion. "By unifying trade relations and managed care under his leadership, we are creating a more integrated approach to how we work with our partners, positioning LUX Infusion to deliver greater value across the entire specialty infusion ecosystem." As SVP, Market Access, Teich will be responsible for developing and executing a comprehensive strategy that aligns the company's market access partnerships across pharmaceutical manufacturers, specialty distributors, group purchasing organizations, and health plan payors with LUX Infusion's mission to expand patient access to high-quality, accessible infusion care. Teich brings more than 15 years of expertise in pharmacy operations, supply chain management, contract negotiation, and executive leadership across the specialty infusion, health system, and retail pharmacy sectors. Prior to joining LUX Infusion, he served as Vice President of Health Systems Manufacturer Relations at Cencora (formerly AmerisourceBergen), where he led negotiations of specialty and biosimilar GPO contracts for health systems, consistently exceeding fiscal-year performance targets. Before Cencora, Teich served as Vice President of Pharmacy Purchasing and Contracting at M Health Fairview, overseeing nearly $1 billion in annual drug spend and driving significant margin improvements through strategic contracting. As Program Manager of Home Infusion and Compounding at the same organization, he grew home infusion revenue by more than 240% over four years. He also held leadership roles at PharMerica and Walgreens. Teich holds a Doctor of Pharmacy (Pharm.D.) from North Dakota State University and has been a licensed pharmacist in Minnesota since 2007. "The convergence of trade relations and managed care under a unified market access function is a natural evolution for LUX Infusion as we scale nationally," said Teich. "I'm energized by the opportunity to work even more closely with our manufacturer, distribution, and payor partners to remove barriers and ensure patients receive the therapies they need, when and where they need them." This leadership structure reflects LUX Infusion's broader commitment to building a fully integrated infusion services platform that leverages strong partner relationships to drive superior clinical outcomes, operational efficiency, and expanded patient access as the company continues its growth toward more than 50 infusion locations nationwide. About LUX Infusion. LUX Infusion is elevating infusions into an experience. As a U.S. based, clinician-led infusion services company, it provides both home infusion and ambulatory infusion center services, bringing clarity, compassion, and expertise to every patient relationship. With faster therapy starts, dedicated patient support, and continuous data sharing with providers, LUX Infusion ensures patients feel supported, and providers and partners can trust in better adherence and outcomes. Media Contact: Tara Marchese Senior Director of Marketing, LUX Infusion Tel: 954-908-7636 Email: [email protected]

PR Newswire
Oct 20th, 2025
BioMatrix Infusion Pharmacy Closes Acquisition of LUX Infusion, Expanding National Ambulatory Infusion Footprint

PLANTATION, Fla., Oct. 20, 2025 /PRNewswire/ -- BioMatrix Infusion Pharmacy today announced the successful acquisition of LUX Infusion, Alaska's premier ambulatory infusion center business, effective October 17, 2025. LUX operates three state-of-the-art infusion centers across Alaska, delivering high-quality, patient-centered care and earning a strong reputation for clinical excellence and trusted provider and payer partnerships."Our decision to acquire LUX Infusion is rooted in a shared commitment to advancing access, quality, and innovation in ambulatory infusion care," said Ted Kramm, Chief Executive Officer, BioMatrix Infusion Pharmacy. "Together, we are better positioned to transform infusion care delivery and ensure that patients nationwide receive the highest standard of treatment.""We founded LUX to deliver clinical excellence in a setting of comfort and convenience. Proving this model in Alaska, while lowering costs for complex treatments, exceeded our expectations," said Lisa Bruce, Co-Founder of LUX Infusion. "Partnering with BioMatrix strengthens our commitment and allows us to expand this model nationwide, raising the standard of outpatient infusion care with partners who share our vision and values."Strategic Benefits of the AcquisitionThrough the integration of LUX Infusion, BioMatrix strengthens its national platform in several key ways:Expand Our Reach: Adds three premier infusion centers in Alaska, advancing BioMatrix's ability to serve patients in key growth markets and meet the rising demand for infusion services.Enhance Clinical Capabilities: Integrates LUX's highly skilled care teams and proven operating model into BioMatrix's growing nationwide network.Accelerate Growth & Innovation: Combines resources to scale new infusion sites more efficiently and deliver expanded therapy options.Expand Home Infusion Nursing: Extends BioMatrix's home infusion nursing capabilities into the Pacific Northwest, providing greater flexibility and access for patients who prefer care in the home setting.Deliver Greater Value: Improves access, outcomes, and experiences for patients while deepening partnerships with providers and payers.LUX Infusion has recently received NICA accreditation and designation of AICE-Ambulatory Infusion Center of Excellence, which reflects their unwavering commitment to delivering safe, high-quality and value-based infusion care.With this acquisition, BioMatrix continues to evolve into one of the nation's most comprehensive infusion pharmacy providers—extending its reach into the Pacific Northwest and reinforcing its commitment to delivering best-in-class care for complex and chronic conditions.About BioMatrix Infusion PharmacyBioMatrix Infusion Pharmacy is a trusted, independent specialty infusion pharmacy with decades of experience